STOCK TITAN

Aemetis, Inc. (DE) - AMTX STOCK NEWS

Welcome to our dedicated page for Aemetis (DE) news (Ticker: AMTX), a resource for investors and traders seeking the latest updates and insights on Aemetis (DE) stock.

Aemetis, Inc. (NASDAQ: AMTX), headquartered in Cupertino, California, is a leading renewable natural gas and renewable fuels company dedicated to the development and commercialization of innovative technologies that aim to replace traditional petroleum-based products. Established in 2006, Aemetis has grown to become a significant player in the renewable energy sector, focusing on the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries.

The company owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto. This plant produces low carbon renewable fuel ethanol, Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all sold to local dairies and feedlots as animal feed. Additionally, Aemetis operates a 60 million gallon per year production facility on the East Coast of India, producing high-quality distilled biodiesel and refined glycerin for customers in India, the US, and Europe.

Aemetis is also spearheading the development of the Carbon Zero sustainable aviation fuel (SAF) and renewable diesel fuel biorefineries in California. These facilities will utilize renewable hydrogen, hydroelectric power, and renewable oils to produce low carbon intensity renewable jet and diesel fuel. The company's biogas operations include a network of dairy biomethane digesters in California’s Central Valley, producing renewable natural gas (RNG) from dairy waste methane.

In recent developments, Aemetis has secured $200 million in EB-5 program investment for its Riverbank sustainable aviation fuel plant, dairy RNG project, carbon sequestration project, and energy efficiency upgrades to the Keyes ethanol plant. The company has also received Authority to Construct permits for its Riverbank SAF/RD plant, expected to produce up to 78 million gallons per year of SAF. Furthermore, Aemetis has been awarded $10.5 million of Inflation Reduction Act (IRA) tax credits to support energy efficiency projects at the Keyes facility.

Financially, Aemetis continues to show robust growth. In the latest earnings report, the company generated $186.7 million in total revenue for the year 2023, with significant increases from its India Biodiesel segment. Aemetis is on track to achieve its ambitious Five-Year Plan, projecting $1.95 billion in revenues and $645 million of adjusted EBITDA by 2028.

Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has secured a $24 million initial purchase order for sanitizer alcohol and nitrile gloves through its subsidiary, Aemetis Health Products. This agreement with a California distributor aims to supply health safety products across various governmental and healthcare entities in the U.S.

With its plant reportedly becoming the largest sanitizer alcohol producer in the Western U.S., Aemetis is expanding its product line to include nitrile gloves, leveraging its extensive experience in Asian markets. A credit facility has been negotiated to support these health safety product transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
none
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) announced that its subsidiary, Aemetis Biogas LLC, received $7.8 million in grants from the California Department of Food and Agriculture's DDRDP, equating to nearly 50% of the total funds awarded. This funding supports the installation of dairy digesters to produce renewable natural gas, expected to eliminate 2.6 million metric tons of CO2 and generate over 100 jobs. The company plans to accelerate the construction of 16 additional digesters and a biogas facility, aiming for RNG injection into PG&E’s pipeline by Q1 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.98%
Tags
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ:AMTX) reported its financial results for Q3 2020, showing revenues of $40.9 million, down from $57.4 million in Q3 2019. The net loss was $12.2 million, compared to $7.2 million the previous year. Ethanol and high-grade alcohol sales increased by 11%, while biodiesel sales surged 216% compared to Q2 2020. The company achieved milestones in its dairy biogas project and launched Aemetis Health Products to meet sanitizer demand. Total revenues for the first nine months of 2020 were $128.2 million, an 14.6% decline from 2019.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-39.26%
Tags
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) will host a conference call to discuss its third quarter 2020 earnings report on November 12, 2020, at 11 am PST. Interested parties can participate via toll-free and international dial-in numbers or through a webcast available on the company's website. The earnings report will be accessible after November 19, 2020, for further review. Aemetis is engaged in renewable fuels and biochemical technologies, operating facilities in California and India, with a focus on converting traditional petroleum products into advanced biorefineries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has initiated production of dairy biogas from two dairies as part of a larger 17-dairy biogas project. This below-zero carbon intensity gas is being used for ethanol production at the Aemetis facility in California. The company plans to scale up its operations, adding 15 more digesters and related infrastructure. The funding plan for this project includes over $65 million in preferred equity and grants. This initiative provides a new revenue stream for local dairies and meets California's methane emission reduction goals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.29%
Tags
none
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has initiated production of hand sanitizer under its Aemetis Health Products label, targeting government and consumer markets. The company's California facility is noted as the largest hand sanitizer alcohol producer in the Western U.S., eliminating long transport times for sanitizer products. Aemetis hand sanitizer contains 70% to 80% alcohol, meeting FDA standards. The company aims to provide safe, domestic products while supporting U.S. jobs and addressing the demand for sanitizer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.21%
Tags
none
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has successfully closed its Phase I EB-5 Program, raising $35.5 million from 71 foreign investors. The funds will generate direct and indirect jobs at its ethanol plant in California. All investors have been vetted by the U.S. Department of Homeland Security and granted conditional permanent residency. Aemetis plans to initiate a Phase II offering, targeting an additional $50 million to create approximately 2,000 jobs for 200 investors. The project has gained National Interest Expedite (NIE) approval for expedited processing of investor applications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.13%
Tags
none
-
Rhea-AI Summary

Aemetis (NASDAQ: AMTX) announced FDA approval for the production and marketing of Over The Counter sanitizer products through its subsidiary, Aemetis Health Products. This registration allows Aemetis to meet the rising demand for hand sanitizers and related products during the COVID-19 pandemic, positioning the company as a unique large-scale sanitizer alcohol producer in the Western U.S. The global hand sanitizer market was valued at approximately $2.9 billion in 2019 and has seen significant growth due to the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.89%
Tags
none
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has completed the construction of its first two dairy digesters and a four-mile pipeline for producing Renewable Natural Gas (RNG). This project aims to supply below-zero carbon intensity RNG, replacing petroleum-based natural gas at its Keyes ethanol facility and fueling RNG trucks and buses. The company is also advancing its Central Dairy Digester Project with plans for additional dairy partnerships and pipeline installations. These initiatives are expected to enhance revenue and reduce carbon intensity while supporting the conversion of methane from dairy waste into sustainable energy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.84%
Tags
none
Rhea-AI Summary

Aemetis announced on August 18, 2020, that it has regained compliance with NASDAQ Listing Rules. The company received confirmation from NASDAQ that it has maintained a minimum market value of publicly held shares of $15 million and a closing bid price of at least $1.00 per share for 10 consecutive trading days. This compliance determination resolves prior concerns regarding its listing status. Aemetis specializes in advanced renewable fuels and biochemicals, operating facilities in California and India, and is engaged in innovative projects aimed at producing sustainable energy alternatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.68%
Tags
none

FAQ

What is the current stock price of Aemetis (DE) (AMTX)?

The current stock price of Aemetis (DE) (AMTX) is $3.01 as of December 13, 2024.

What is the market cap of Aemetis (DE) (AMTX)?

The market cap of Aemetis (DE) (AMTX) is approximately 144.7M.

What does Aemetis, Inc. do?

Aemetis, Inc. is a renewable fuels and biochemicals company focused on developing technologies to replace traditional petroleum-based products through the conversion of ethanol and biodiesel plants into advanced biorefineries.

Where is Aemetis headquartered?

Aemetis, Inc. is headquartered in Cupertino, California.

What are the key products of Aemetis?

Key products of Aemetis include renewable natural gas (RNG), ethanol, biodiesel, distilled biodiesel, refined glycerin, and sustainable aviation fuel (SAF).

What recent financial achievements has Aemetis made?

In 2023, Aemetis generated $186.7 million in total revenue, with significant contributions from its India Biodiesel segment.

What is Aemetis' Five-Year Plan?

Aemetis' Five-Year Plan projects $1.95 billion in revenues and $645 million of adjusted EBITDA by 2028, driven by expansions in renewable natural gas, biodiesel, SAF/RD, and carbon capture and sequestration projects.

What recent permits and investments has Aemetis received?

Aemetis received Authority to Construct permits for its Riverbank SAF/RD plant and $200 million in EB-5 program investment for various projects, including energy efficiency upgrades.

What are the main operational facilities of Aemetis?

Aemetis operates a 65 million gallon per year ethanol production facility in California and a 60 million gallon per year biodiesel facility in India.

How does Aemetis contribute to greenhouse gas reduction?

Aemetis' renewable fuels and RNG projects significantly reduce greenhouse gas emissions by replacing fossil fuels and capturing methane emissions from dairy waste.

What partnerships and markets does Aemetis serve?

Aemetis serves markets in the US, India, and Europe and has secured over $3 billion in contracts to supply airlines with sustainable aviation fuel.

What technological advancements is Aemetis involved in?

Aemetis is involved in developing technologies for renewable hydrogen, hydroelectric power, biogas digesters, carbon sequestration, and advanced biorefineries.

Aemetis, Inc. (DE)

Nasdaq:AMTX

AMTX Rankings

AMTX Stock Data

144.73M
45.76M
8%
22.82%
11.14%
Oil & Gas Refining & Marketing
Industrial Organic Chemicals
Link
United States of America
CUPERTINO